Issue 2, 2025

Correction: Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy

Abstract

Correction for ‘Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy’ by Mees M. Hendrikx et al., RSC Med. Chem., 2024, 15, 1652–1663, https://doi.org/10.1039/D4MD00076E.

Associated articles

Article information

Article type
Correction
Submitted
20 Jan 2025
Accepted
20 Jan 2025
First published
03 Feb 2025
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2025,16, 970-970

Correction: Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy

M. M. Hendrikx, A. M. Pereira, A. B. Pereira, C. S. C. Carvalho, J. L. P. Ribeiro, M. I. L. Soares, L. Saraiva and T. M. V. D. Pinho e Melo, RSC Med. Chem., 2025, 16, 970 DOI: 10.1039/D5MD90004B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements